- Release Date: 16/12/24 08:34
- Summary: Weaponising Exosomes for Breast Cancer treatment
- Price Sensitive: Yes
- Download Document 293.65KB
- Forums
- ASX - By Stock
- IIQ
- Ann: Weaponising Exosomes for Breast Cancer treatment
IIQ
inoviq ltd
Add to My Watchlist
4.76%
!
40.0¢

Ann: Weaponising Exosomes for Breast Cancer treatment
Featured News
Add to My Watchlist
What is My Watchlist?
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.
|
|||||
Last
40.0¢ |
Change
-0.020(4.76%) |
Mkt cap ! $44.65M |
Open | High | Low | Value | Volume |
40.0¢ | 40.5¢ | 40.0¢ | $50.02K | 124.9K |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
2 | 16861 | 40.0¢ |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
40.5¢ | 3809 | 1 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
2 | 16861 | 0.400 |
3 | 8000 | 0.390 |
2 | 39000 | 0.385 |
9 | 150179 | 0.380 |
2 | 114000 | 0.375 |
Price($) | Vol. | No. |
---|---|---|
0.405 | 3809 | 1 |
0.425 | 6950 | 1 |
0.430 | 23025 | 3 |
0.440 | 21810 | 2 |
0.445 | 11090 | 2 |
Last trade - 15.40pm 11/08/2025 (20 minute delay) ? |
Featured News
IIQ (ASX) Chart |
The Watchlist
WIN
WIN METALS LTD
Steve Norregard, CEO & MD
Steve Norregard
CEO & MD
SPONSORED BY The Market Online